July 22, 2024 -
Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has
approved the Biologics License Application (BLA) for Epysqli
July 22, 2024 -
The U.S. Food and Drug Administration (FDA) approved Femlyv (norethindrone acetate and ethinyl estradiol), the first orally disintegrating tablet approved for the prevention of pregnancy